September 10-12, 2018
San Diego, CA

2018 Partners

 

Pharma Phorum

Media Partner

Pharma Phorum media is the premier digital publisher of thought leadership relating to the pharmaceutical industry. The news, opinions and insights published every day help industry executives better understand the broader healthcare landscape within which they operate, including regular contributions from their peers, innovative service providers, physicians, payers / policy makers, patient organisations and patients. Core channels include pharmaphorum.com, our new digital journal Deep Dive and a highly engaged social media audience through multiple platforms.

www.pharmaphorum.com

Pharma Journalist 

Media Partner

Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry therefore keeping a tab on the updated and latest updates and trends concerning the field.Our widespread and market specific content write-ups cater to Industry professionals intending to keep pace with this dynamic and revolutionary industry. Articles like latest news, trends, analysis, market reports, press releases, whitepapers, case studies, etc, enable further insight as well as an in-depth interpretation of industry trends. Read More

www.pharmajournalist.com

PharmaVOICE 

Media Partner

PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

www.pharmavoice.com